Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
AcneHeroes.com Puts Focus on Skin Care for Prom Web Site Teams Up with AnnaLynne McCord and Dr. Jeanine Downie to Provide Skin Care Tips and Expert Advice to Look and Feel Your Best by Prom Night Bridgewater, NJ- April 21, 2009 — AcneHeroes.com, a leading Web site that offers a wide array of information on acne and skin care, has teamed up with AnnaLynne McCord and renowned dermatologist, Dr. Jeanine Downie, to launch Skin Care for Prom to help teens get ready for one of the biggest events of the school year. Acne is a challenge for many teens and can be especially difficult to deal with during social milestones. Skin Care for Prom, the newest addition to the site, is dedicated to offering tips ranging from skin care secrets to what to wear. AnnaLynne McCord, who plays Naomi Clark on the hit TV show 90210, has experienced acne breakouts and understands the importance of looking and feeling your best for special events. “Prom is a time when teens want to look their best - from head to toe - and that includes their skin,” says McCord. “Having acne has been a challenge for me as I’m sure it is for many teens. That’s why I got involved with Acneheroes.com – I want to share my secrets for clear skin with teens across the country.” This innovative Web site offers a multitude of resources where teens and their parents can learn about acne from an expert and find AnnaLynne’s skin care tips to look red-carpet ready for the prom. AcneHeroes.com also features a virtual Countdown to Prom calendar where Dr. Downie and AnnaLynne will share a tip-a-day for 30 days to help teens get ready for the big night. "I treat a lot of teens who are dealing with the challenges of acne and looking for guidance before events such as the prom,” says Dr. Downie, director of image Dermatology P.C. in Montclair, N.J and co-author of Beautiful Skin of Color. “In addition to the Web site as a resource for teens, it is also important for parents to take an active role in helping their children seek appropriate treatment from a dermatologist.” Dr. Downie also suggests the following tips to maintain clear skin: • Talk to your parents – If you have occasional breakouts, discuss scheduling an appointment with your dermatologist or pediatrician at least one month prior to prom night to find out about personalized skin care regimens and effective treatments that may be right for you. -more- 1/1 Sanofi-aventis: www.sanofi-aventis.us Media Relations: Tel. : 908-981-6567 E-mail: [email protected] Investor Relations: Tel. : 908-981-5560 E-mail: [email protected] US.CLI.09.02.012 • Cover up– Excessive sun exposure can damage the skin, remember to wear sunscreen. • Makeup rules – Use water-based products and look for products marked "noncomedogenic." Don't sleep with your makeup on — let your skin breathe and don't share makeup with your friends. For more information and tips on how to treat your acne and maintain beautiful, clear skin in time for prom night, visit www.acneheroes.com . About BenzaClin® BenzaClin® is proven effective in treating many kinds of acne, including whiteheads, blackheads, and pimples. In clinical trials, BenzaClin® worked better than either clindamycin or benzoyl peroxide alone for the topical treatment of acne. With BenzaClin®, improvements have been shown to occur in as early as two weeks. BenzaClin® is indicated for the topical treatment of acne. Important Safety Information IMPORTANT SAFETY INFORMATION BenzaClin® was studied in mild to moderate acne patients. BenzaClin® is an acne product you can get with a doctor's prescription. Side effects are usually limited to the skin and include dry skin, itching, peeling, redness and sunburn. Also, clindamycin, an ingredient in BenzaClin®, may cause diarrhea. If you experience severe diarrhea, stop using BenzaClin® and call your doctor immediately. You should not use BenzaClin® if you are allergic to clindamycin, benzoyl peroxide, or the antibiotic lincomycin, or if you have a history of colitis. Please see full prescribing information at www.benzaclin.com. About sanofi-aventis Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. Sanofiaventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). For more information, www.sanofi-aventis.us or www.sanofi-aventis.com Forward Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans” and similar expressions. Although sanofiaventis’ management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in sanofi-aventis’ annual report on Form 20-F for the year ended December 31, 2008. Other than as required by applicable law, sanofiaventis does not undertake any obligation to update or revise any forward-looking information or statements. Contacts US: Amy Ba, sanofi-aventis, (908)-981-6563 or [email protected] 2/2 US.CLI.09.02.012